2 results
Approved WMORecruiting
To study the effectiveness of low-frequency rTMS in patients with chronic tinnitus.
Approved WMOCompleted
To estimate the bleeding risk with rivaroxaban, compared with ASA, in addition to a singleantiplatelet agent (clopidogrel or ticagrelor), in subjects with a recent ACS .